CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Mar. 01, 2018	Mar. 02, 2017
Cash flows from operating activities
Net income	$ 5,989	$ 1,074
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation expense and amortization of intangible assets	2,241	1,774
Amortization of debt discount and other costs	55	63
Loss on debt repurchases and conversions	218	1
Stock-based compensation	103	101
Gain on remeasurement of previously-held equity interest in Inotera	0	(71)
Change in operating assets and liabilities
Receivables	(630)	(773)
Inventories	(62)	174
Accounts payable and accrued expenses	93	399
Payments attributed to intercompany balances with Inotera	0	(361)
Deferred income taxes, net	(262)	59
Other noncurrent liabilities	229	(23)
Other	10	126
Net cash provided by operating activities	7,984	2,543
Cash flows from investing activities
Expenditures for property, plant, and equipment	(4,217)	(2,428)
Purchases of available-for-sale securities	(502)	(803)
Payments to settle hedging activities	(28)	(249)
Acquisition of Inotera	0	(2,634)
Proceeds from sales of available-for-sale securities	562	548
Proceeds from maturities of available-for-sale securities	138	72
Proceeds from settlement of hedging activities	111	74
Other	93	35
Net cash provided by (used for) investing activities	(3,843)	(5,385)
Cash flows from financing activities
Repayments of debt	(3,379)	(556)
Payments on equipment purchase contracts	(153)	(33)
Proceeds from issuance of stock	1,554	68
Proceeds from issuance of debt	650	2,961
Other	(92)	(99)
Net cash provided by (used for) financing activities	(1,420)	2,341
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	4	(33)
Net increase (decrease) in cash, cash equivalents, and restricted cash	2,725	(534)
Cash, cash equivalents, and restricted cash at beginning of period	5,216	4,263
Cash, cash equivalents, and restricted cash at end of period	$ 7,941	$ 3,729